Stan Micek joined MiMedx in December, 2019. Prior to joining the Company, Mr. Micek served as the Vice President and Chief Commercial Officer for M2Gen, Corp. where he was responsible for all commercialization activities of the company including business development, strategic alliances, field sales and corporate communications.
From 2014 to 2018, Mr. Micek served as the Director, Oncology Commercialization at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) and Director of Licensing for The Ohio State University’s (OSU) Technology Commercialization Office. Prior to joining OSU, he held executive roles within two mid-sized pharmaceutical companies leading their corporate and business development functions, specifically in- and out-licensing, acquisitions, and divestitures. Mr. Micek also brings nineteen years of experience from Abbott Laboratories, where he held positions of increasing responsibility in several functional areas, including national account sales, marketing, business development and licensing, engineering and international manufacturing/ operations.
Mr. Micek earned his BS in Chemical Engineering from the Illinois Institute of Technology in Chicago and his MBA in Marketing and International Management from Northwestern University’s Kellogg Graduate School of Management in Evanston, IL.